The pan-Canadian Pharmaceutical Alliance and the Canadian Generic Pharmaceutical Association extend agreement on pricing initiative for generic drugs
11 June 2026
The CGPA and its Biosimilars Canada division welcome the Ontario government’s announcement of a $146 million investment in the next phase of its Life Sciences Strategy to help position the province as a global leader in life sciences.